Topline Capital Management, LLC, Topline Capital Partners, LP, and Collin McBirney filed an amended beneficial ownership statement with the SEC on November 16, 2026, disclosing a combined 705,696-share position in Nephros Inc. common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: 705,696 shares of Nephros Inc. common stock, representing 6.4% of the class, as of November 13, 2026.
  • Triggering event date: September 30, 2026, cited as the date of the event requiring the filing.
  • Three reporting persons: Topline Capital Management, LLC (California); Topline Capital Partners, LP (Delaware); and Collin McBirney (United States), serving as member-manager of TCM.
  • Voting and dispositive power: Topline Capital Management and Topline Capital Partners each report sole voting and dispositive power over all 705,696 shares; Collin McBirney reports shared voting and shared dispositive power over the same 705,696 shares.
  • Shares held for fund's benefit: According to the filing, the securities "are held by and for the benefit of the Fund," referring to Topline Capital Partners, LP.
  • Beneficial ownership disclaimer: The filing states that "neither the filing of this Schedule nor any of its contents shall be deemed to constitute an admission" that TCM or Mr. McBirney is the beneficial owner for any other purpose, with each expressly disclaiming beneficial ownership except to the extent of pecuniary interests.

Topline Capital's Reported Position in Nephros Inc.

According to the amended filing, Topline Capital Management, LLC serves as investment manager and general partner of Topline Capital Partners, LP, with Collin McBirney acting as member-manager of Topline Capital Management. The filing reports that as of November 13, 2026, the fund beneficially owns 705,696 shares of Nephros Inc. common stock, equaling 6.4% of the outstanding class. Nephros Inc., listed on NASDAQ:NEPH, is a medical device and water purification company headquartered at 380 Lackawanna Place, South Orange, New Jersey 07079.

The filing distinguishes voting and dispositive authority among the three reporting persons. Topline Capital Management and Topline Capital Partners each report sole voting power and sole dispositive power over all 705,696 shares, with no shared power. Collin McBirney, by contrast, reports zero sole voting or dispositive power, but reports shared voting power and shared dispositive power over the same 705,696 shares. The filing notes that individual general partners, executive officers, and members "might be deemed the beneficial owners of some or all of the Securities insofar as they may be deemed to share the power to direct the voting or disposition" of those shares.

The reporting persons' principal business address is listed as 544 Euclid Street, Santa Monica, California 90402. The common stock carries a par value of $0.001 per share and is identified by CUSIP number 640671400. This filing is designated Amendment No. 1, indicating a prior statement was on record for this position.

What Was Disclosed

Three affiliated reporting persons, Topline Capital Management, Topline Capital Partners, and Collin McBirney, disclosed a combined 705,696-share beneficial ownership position in Nephros Inc. common stock, equaling 6.4% of the class, through an amended ownership statement tied to a September 30, 2026 triggering event.